preclinics logotype

News feed

Get the latest updates in your mailbox by subscribing to our newsletter.

 
News item

preclinics certified products GmbH

13/01/2023 **preclinics proudly presents our new subsidiary *preclinics certified products GmbH*** More info…
News item

ELISpot

20/12/2022 **ELISpot – a sensitive method to study the immune response on cellular levels** (image: astor-apex-web-4-webseite.jpg) More info…
News item

UK B1.1.7 SARS-CoV-2 pseudoviruses

22/02/2021 **UK B1.1.7 SARS-CoV-2 pseudoviruses available for Neutralization assay: **Preclinics is offering its Customers the Pseudoviral Infection/Neutralization assay with recent mutated strain B1.1.7. (image: 21b-05-014_b117-infection.jpg) (image: pexels-cdc-3992933.jpg) Photo by CDC from Pexels
News item

SARS-CoV-2 and COVID-19 research

10/08/2020 preclinics is developing assays for SARS-CoV-2 and COVID-19 research. Now our virus neutralizing assays are available to test the neutralizing effect of antibodies and sera. Assays for protease inhibitors, as well as in vivo models in K18-huACE2 mice will follow soon. For covid19 research we have a lung inflammation model established. (image: noname015.jpg) More info…
News item

COVID-19 neutralization assay

27/11/2020 COVID-19 Pseudovirus Infection and Neutralisation Service Preclinics GmbH offers its customers Covid-19 pseudotyped viruses infection and neutralization services in vitro and ex vivo. This service is based on the crucial interaction of trimeric Spike protein of SARS-Cov2 with its eukaryotic counter receptor ACE2. This service can be used for: 1. Screening patient serum for neutralizing antibodies 2. Validating inhibitors of the Spike-ACE2 interaction 3. COVID-19 vaccine development **Assay lay out** (image: neutralization-assay-layout_small.jpg) More info…